All lobbying filings

MEHLMAN CONSULTING, INC.

Lobbying for AMERICA'S HEALTH INSURANCE PLANS

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$90,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 4

HR 247
Health Care Affordability Act of 2025
S 46
Health Care Affordability Act of 2025
HCONRES 14
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appro…
S 1105
No UPCODE Act

Lobbying activity 4

Taxation/Internal Revenue Code

Enhanced premium tax credits Issues related to HSAs. H.R.247/S.46 - Health Care Affordability Act of 2025

Pharmacy

Prescription drug pricing.

Health Issues

Advanced premium tax credits. Prescription drug pricing. Issues related to cybersecurity. PL 119-21 - An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Medicare/Medicaid

Issues related to Medicare payments and Medicare Advantage Prescription Drug Pricing. Medicaid S.1105 - No UPCODE Act PL 119-21 - An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.